Atlas Trials

Live Attenuated Influenza Vaccine

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Live Attenuated Influenza Vaccine

RecordFirmDate
A Phase III/IV Open-label Study of the Immunogenicity and Safety of a Single Dose of a Live Attenuated Influenza Vaccine (LAIV) (FluenzTM) for Each of Three Successive Years in Children naïve to, or in Previous Receipt of the AS03B Adjuvanted H1N1 (2009) Influenza Vaccine (Pandemrix ™). (NCT02143882)Public Health England2014-09-01

Track Live Attenuated Influenza Vaccine automatically

Every clearance here is in the API, with alerts when new ones post.